These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 39275009

  • 1. Exploration of Compounds with 2-Phenylbenzo[d]oxazole Scaffold as Potential Skin-Lightening Agents through Inhibition of Melanin Biosynthesis and Tyrosinase Activity.
    Jung HJ, Park HS, Park HS, Kim HJ, Yoon D, Park Y, Chun P, Chung HY, Moon HR.
    Molecules; 2024 Sep 02; 29(17):. PubMed ID: 39275009
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and anti-melanogenic effect of cinnamamide derivatives.
    Ullah S, Park Y, Ikram M, Lee S, Park C, Kang D, Yang J, Akter J, Yoon S, Chun P, Moon HR.
    Bioorg Med Chem; 2018 Nov 15; 26(21):5672-5681. PubMed ID: 30366788
    [Abstract] [Full Text] [Related]

  • 3. Urolithin and Reduced Urolithin Derivatives as Potent Inhibitors of Tyrosinase and Melanogenesis: Importance of the 4-Substituted Resorcinol Moiety.
    Lee S, Choi H, Park Y, Jung HJ, Ullah S, Choi I, Kang D, Park C, Ryu IY, Jeong Y, Hwang Y, Hong S, Chun P, Moon HR.
    Int J Mol Sci; 2021 May 25; 22(11):. PubMed ID: 34070680
    [Abstract] [Full Text] [Related]

  • 4. Novel Anti-Melanogenic Compounds, (Z)-5-(Substituted Benzylidene)-4-thioxothiazolidin-2-one Derivatives: In Vitro and In Silico Insights.
    Choi H, Ryu IY, Choi I, Ullah S, Jung HJ, Park Y, Jeong Y, Hwang Y, Hong S, Yoon IS, Yun H, Kim MS, Yoo JW, Jung Y, Chun P, Moon HR.
    Molecules; 2021 Aug 17; 26(16):. PubMed ID: 34443550
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
    Mann T, Gerwat W, Batzer J, Eggers K, Scherner C, Wenck H, Stäb F, Hearing VJ, Röhm KH, Kolbe L.
    J Invest Dermatol; 2018 Jul 17; 138(7):1601-1608. PubMed ID: 29427586
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of N-(acryloyl)benzamide derivatives on tyrosinase and melanogenesis.
    Lee S, Ullah S, Park C, Won Lee H, Kang D, Yang J, Akter J, Park Y, Chun P, Moon HR.
    Bioorg Med Chem; 2019 Sep 01; 27(17):3929-3937. PubMed ID: 31345746
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells.
    Ullah S, Kang D, Lee S, Ikram M, Park C, Park Y, Yoon S, Chun P, Moon HR.
    Eur J Med Chem; 2019 Jan 01; 161():78-92. PubMed ID: 30347330
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antioxidant, anti-tyrosinase and anti-melanogenic effects of (E)-2,3-diphenylacrylic acid derivatives.
    Ullah S, Park Y, Park C, Lee S, Kang D, Yang J, Akter J, Chun P, Moon HR.
    Bioorg Med Chem; 2019 Jun 01; 27(11):2192-2200. PubMed ID: 31027707
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the Novel Synthetic Tyrosinase Inhibitor (Z)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) In Vitro and In Silico.
    Bang E, Noh SG, Ha S, Jung HJ, Kim DH, Lee AK, Hyun MK, Kang D, Lee S, Park C, Moon HR, Chung HY.
    Molecules; 2018 Dec 13; 23(12):. PubMed ID: 30551624
    [Abstract] [Full Text] [Related]

  • 19. Novel synthetic kojic acid-methimazole derivatives inhibit mushroom tyrosinase and melanogenesis.
    Chen MJ, Hung CC, Chen YR, Lai ST, Chan CF.
    J Biosci Bioeng; 2016 Dec 13; 122(6):666-672. PubMed ID: 27353860
    [Abstract] [Full Text] [Related]

  • 20. Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.
    Abbas Q, Ashraf Z, Hassan M, Nadeem H, Latif M, Afzal S, Seo SY.
    Drug Des Devel Ther; 2017 Dec 13; 11():2029-2046. PubMed ID: 28740364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.